Edition:
United States

Sichuan Kelun Pharmaceutical Co Ltd (002422.SZ)

002422.SZ on Shenzhen Stock Exchange

17.67CNY
21 Sep 2017
Change (% chg)

¥-0.05 (-0.28%)
Prev Close
¥17.72
Open
¥17.66
Day's High
¥17.81
Day's Low
¥17.64
Volume
4,336,112
Avg. Vol
4,703,919
52-wk High
¥18.51
52-wk Low
¥14.78

Select another date:

Tue, Sep 5 2017

BRIEF-Sichuan Kelun Pharmaceutical issues 2017 1st tranche medium term notes worth 1.4 bln yuan

* Says it completed issuance of 2017 1st tranche medium term notes worth 1.4 billion yuan

BRIEF-Sichuan Kelun Pharmaceutical buys back 33.3 mln yuan worth of company shares

* Says it buys back 33.3 million yuan(0.15 percent stake) worth of company shares

BRIEF-Sichuan Kelun Pharmaceutical to set up JV in Kazakhstan

* Says co and an individual plan to jointly invest $100,000 to set up a joint venture (JV) KELUN MODERN AGRIBUSINESS CO., LTD. in Kazakhstan

BRIEF-Sichuan Kelun Pharmaceutical unit signs license agreement with Pieris Pharmaceuticals

* Says its Sichuan-based unit signs license agreement with Pieris Pharmaceuticals Inc, regarding a patent of tumour immunotherapy

BRIEF-Sichuan Kelun Pharmaceutical's shareholder cuts stake in the company

* Says its shareholder has unloaded 1.6 percent stake in the company on July 28, taking his holdings to 5.2 percent after transaction

BRIEF-Sichuan Kelun Pharmaceutical issues 2017 2nd tranche corporate bonds worth 600 mln yuan

* Says it completed issuance of 2017 2nd tranche public corporate bonds worth 600 million yuan

BRIEF-Sichuan Kelun Pharmaceutical sets coupon rate of 2017 2nd tranche corporate bonds at 5.38 pct

* Says it sets coupon rate of 2017 2nd tranche public corporate bonds at 5.38 percent

BRIEF-Sichuan Kelun Pharma expects H1 net profit to fall 20-35 pct y/y

* Says it expects H1 net profit to fall 20-35 percent y/y from 386.1 million yuan ($56.93 million) year ago

BRIEF-Sichuan Kelun Pharmaceutical issues 2017 4th tranche super short-term financing notes worth 1 bln yuan

* Says it completed issuance of 2017 4th tranche super short-term financing notes worth 1 billion yuan

BRIEF-Sichuan Kelun Pharmaceutical gets approval to issue 3 bln yuan commercial paper

* Says it gets approval to issue 3.0 billion yuan ($435.13 million) commercial paper

Select another date: